Andorra vs Europe: Proportion of the target population who received the final dose of
Andorra
82.0%
in 2024
Europe
40.0%
in 2024
Andorra rank
20th
Europe rank
21st
Proportion of the target population who received the final dose of over time
- Andorra
- Europe
How they compare
Andorra currently reports 82.0% against 40.0% in Europe, a difference of 42.0%.
That makes Andorra's figure about 2.0 times Europe's.
Across all 7 years both countries report, Andorra has been ahead every year.
Andorra ranks 20th and Europe ranks 21st of 107 countries.
Andorra has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Andorra | Europe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 56.5% | 34.5% | 22.0% | Andorra |
| 2020s | 82.0% | 36.8% | 45.2% | Andorra |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Andorra or Europe?
- Andorra, at 82.0% against 40.0% in Europe as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Andorra and Europe?
- 42.0%, with Andorra ahead.
- How many years of comparable data are there for Andorra and Europe?
- 7 years are reported by both, from 2018 to 2024.
- How do Andorra and Europe rank globally for proportion of the target population who received the final dose of?
- Andorra ranks 20th and Europe ranks 21st of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.